[Successful Treatment of Neonatal Respiratory Transitional Disorder with Pulmo/Vivianit comp. in 2 Cases]

Complement Med Res. 2017;24(3):172-174. doi: 10.1159/000475906. Epub 2017 Jun 12.
[Article in German]

Abstract

Background: Disorders of the respiratory transition at birth are major reasons for neonates being admitted to intensive care units and separated from their mothers. This has potential long-lasting consequences for the mother-infant interaction as well as the long-term development of the child. There is an urgent need for effective preventive and therapeutic measures for this frequent disorder.

Case report: We report the cases of 2 newborn infants with respiratory transitional disorder treated off-label with the anthroposophic medicament Pulmo/Vivianit comp. based on pathophysiological considerations and on particular parental request. In both cases, an immediate and sustainable response could be documented without adverse effects.

Conclusion: This new therapeutic approach merits further attention in clinical research but cannot be recommended for routine practice before more high-level evidence is available.

Keywords: Anthroposophic medicine; Mother-infant separation; Neonatology; Pulmo/Vivianit comp.; Respiratory distress syndrome; Respiratory transition.

Publication types

  • Case Reports

MeSH terms

  • Anthroposophy*
  • Humans
  • Infant, Newborn
  • Materia Medica / therapeutic use*
  • Respiratory Distress Syndrome, Newborn / therapy*
  • Treatment Outcome

Substances

  • Materia Medica